Low-Dose Interleukin-2 Resolves Stress-Induced Chronic Sensitization Independent of Opioid Receptor Signaling
Róli Rodrigues SimõesiD, Scheila Kraus, Jintao ZhangiD, Leandro Flores do Nascimento, Dilip K. ToshiD, Jacqueline Unsinger, Richard S. HotchkissiD, Tao CheiD, Kenneth A. JacobsoniD, Yuqing Q. CaoiD
Abstract
Stress is a common trigger of headache and widespread somatic pain. Repeated exposure to stress establishes latent sensitization that is tonically suppressed by endogenous inhibitory systems. Using brain-penetrating and peripherally restricted receptor antagonists in a mouse model of repetitive restraint stress, we systematically identified these protective pathways. Peripheral kappa opioid receptors as well as GABA type A and type B (GABAA and GABAB) receptors, alongside central opioid and cannabinoid signaling, actively suppress headache-related facial mechanical hypersensitivity in stressed mice. Blocking any pathway quickly reinstated cephalic allodynia. Peripheral opioid and GABAA receptor signaling also inhibited stress-induced latent sensitization on hindpaw. In contrast, depletion of anti-inflammatory regulatory T (Treg) cells prolonged facial but not hindpaw sensitization, suggesting that Tregs preferentially limit stress-induced chronic headache. Next, we administered low-dose interleukin-2 (LD-IL-2) to stressed mice to preferentially expand and activate Treg cells. Following LD-IL-2 treatment, neither subthreshold pain triggers nor blockade of endogenous inhibitory pathways reinstated cephalic or hindpaw allodynia in either sex, indicating elimination of stress-induced sensitization. Mechanistically, LD-IL-2 acted through Treg cells to recruit multiple peripheral cytokine pathways without engaging endogenous opioid, GABA, or cannabinoid receptor signaling. Notably, LD-IL-2 was more effective than anti-CGRP (calcitonin gene-related peptide) therapy in preventing headache-related chronic sensitization in stressed mice. Collectively, these findings reveal multiple central and peripheral pathways that act concertedly to mask stress-induced latent sensitization and strongly support further evaluation of LD-IL-2 as a novel treatment for stress-induced headache and widespread pain with a distinct mechanism of action.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Long-term sensitization of rat spinal neurons induced by adolescent psychophysical stress is further enhanced by a mild-nociceptive lumbar input
Sathish Kumar Singaravelu, Alexander Dawit Goitom, … Rolf‐Detlef Treede·bioRxiv·Apr 30, 2021
- Descending locus coeruleus noradrenergic signaling to spinal astrocyte subset is required for stress-induced mechanical pain hypersensitivity
Riku Kawanabe-Kobayashi, Sawako Uchiyama, … Makoto Tsuda·eLifePeer-reviewed·Mar 9, 2026
- A Src family kinases maintain latent sensitization in rats, a model of inflammatory and neuropathic pain
Wenling Chen, Juan Carlos G. Marvizón·Brain ResearchPeer-reviewed·Jun 21, 2020
- Neurokinin 1 receptor activation in the rat spinal cord maintains latent sensitization, a model of inflammatory and neuropathic chronic pain
Wenling Chen, Juan Carlos G. Marvizón·NeuropharmacologyPeer-reviewed·Jul 29, 2020
- A septo-hypothalamic-medullary circuit directs stress-induced analgesia
Devanshi Piyush Shah, Pallavi Raj Sharma, … Arnab Barik·eLifePeer-reviewed·Jan 20, 2025
- Tonic Meningeal Interleukin-10 Upregulates Delta Opioid Receptor to Prevent Relapse to Pain
Kufreobong E. Inyang, Jaewon Sim, … Geoffroy O. Laumet·Brain, Behavior, and ImmunityPeer-reviewed·Jan 1, 2025